Notizia: The Latest Pharma, Healthcare and Biotech Event Archives
Fight Against the Antibiotic Resistance in the Uncomplicated Urinary Tract Infections Market
Pharma news
Evotec, Vifor Pharma collaborates to ...

Switzerland-based Vifor Pharma and Germany-based Evotech AG have collaborated for the development and disco...

Pharma News
AstraZeneca tops the first Pharma Inv...

Amgen has announced to purchase 20.5% of the stake in Chinese-American drug company BeiGene. As per the dea...

Pharma News
AZ sells EU rights for Schizophrenia ...

AstraZeneca has announced the licensing-out of two of its drugs Seroquel and Seroquel XR in Europe and Russ...

Pharma News
AZ announces positive results for durvalumab and tremelimumab; FDA nods to extend LILETTA’s use t...

AstraZeneca recently has announced the results of the clinical trials POSEIDON which included the study of a combination of drugs Imfinzi (durvalumab) and tremelimumab with chemotherapy in lung ca...


pharma news
Rapt Therapeutics files IPO; Novartis stakes $80M for NASH

Rapt Therapeutics files for IPO at $75MRapt Therapeutics, based in the US, filed to raise to $75 million in its IPO. This had come after five months when the company had retitled itself, which...


Pharma news
FDA approval to AZ’s Farxiga for heart failure; GSK divests two travel vaccines to Bavarian Nord...

The US FDA today has given its nod to Trikafta (elexacaftor/ivacaftor/tezacaftor) of Vertex Pharmaceuticals, the first of its kind triple combination therapy for the patients with cystic fibrosis....


Pharma News
EicOsis receives USD 15M to fuel its non-opioid pain therapy; Alexion Pharmaceuticals buys Achill...

EicOsis has received USD 15Million grant from the National Institute of Drug Abuse (NIDA) to fund the clinical trials of non-opioid pain therapy.NIDA, with an aim to supplement NIH’s initiati...


Pharma News
ImaginAb joins hands with AstraZeneca, Pfizer, Takeda

ImaginAb has collaborated with AstraZeneca, Pfizer and Takeda to develop technology to facilitate tumour imaging and monitoring inside the cells.ImaginAb is an emerging imaging company focuse...


World Pharma News
AngioDynamics acquires Eximo; MiroBio raises USD 33 M; Janssen submits sBLA for Stelara

AngioDynamics, an innovative medical devices provider, has signed an upfront USD 46 Million deal to acquire Eximo Medical.AngioDynamics is a leading player in manufacturing medical devices fo...


Cocaine Use Disorder
Cocaine Use Disorder...

Cocaine Use Disorder (CUD) is characterized as a substance use disorder in which biological, psychol.....

Cardiovascular Disease Devices Whitepaper
Cardiovascular Disease De...

Today, the sedentary lifestyle adopted among people has led to cause a myriad of underlying diseases.....

Lupus Nephritis
Lupus Nephritis...

Lupus Nephritis (LN) is one of the most common manifestations of systemic lupus erythematosus (SLE),.....

Editor's Pick
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia G...

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...

Scrutinizing the West Syndrome Market Space from Growth Perspectives

West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...

Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the...

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...